sodium chloride absorption and also inhibited passive secretion induced by mannitol. VIP reduced the lumen-to-plasma unidirectional sodium and chloride flux rates, while the plasma-to-lumen flux rates were decreased to a lesser extent or remained unchanged. The potential difference became more lumen-negative with VIP, but the sodium diffusion and glucose-stimulated potential were not affected. We conclude that the major effect of VIP in the human jejunum is to decrease the normal absorption of water and electrolytes-not only active bicarbonate-mediated absorption, but also the passive absorption in response to osmotic forces generated by active or facilitated absorptive processes.
INTRODUCTION
Previous work has shown that high mucosal concentrations of cyclic AMP stimulate active chloride secretion and inhibit sodium chloride absorption in the intestine of laboratory animals in vitro (1) . Since vaso-active intestinal polypeptide (VIP)' causes an increase in mucosal concentration of cyclic AMP (2) , it is generally assumed that severe diarrhea seen in patients with VIP-producing tumors is caused by stimulation of active chloride secretion and by a simultaneous inhibition of normal sodium chloride absorption. It was the purpose of this study to determine the relative importance of each of these cyclic AMP effects in man in vivo. This was done by examining the response of the human jejunum to intravenously infused VIP. The jejunum was selected for study because it is in this part of the intestine that water and electrolyte transport is most deranged in patients with diarrhea due to VIP-secreting endocrine tumors (3) .
It is known from previous work that the normal human jejunum in vivo actively absorbs bicarbonate via a Na/H exchange (4) , and that to a lesser extent it actively secretes chloride (5) . The mucosa is highly permeable to sodium chloride (6) , and passive sodium chloride absorption or secretion is quantitatively a major mechanism for salt transport in this part of the human intestine (7) . Therefore, in our studies we paid particular attention to the effect of VIP on active bicarbonate absorption, on active chloride secretion, and on passive absorption and secretion of sodium chloride.
VIP was infused intravenously at a rate of 200 or 400 pmol/kg per h, since previous studies have shown that this rate of infusion elevates plasma VIP concentration into the range found in patients with diarrhea associated with VIP-producing tumors (8) . Use of higher doses is limited by side effects which include tachycardia, intense flushing, headache, and fatigue.
METHODS
Subjects. Normal volunteers, aged 21-37 yr, were studied.
Informed written consent was obtained from each subject. I Abbreviations used in this paper: PD, potential difference; PEG, polyethylene glycol; VIP, vasoactive intestinal polypeptide. Jejunal perfusion. Using the triple-lumen tube method, jejunal perfusion was carried out in the standard manner (9) when the infusion site was located at the ligament of Treitz. The mixing segment was 10 cm, and unless otherwise stated, the test segment was 30 cm, and the test solutions were perfused at 10 ml/min. The makeup of the test solutions is shown in Table I . Polyethylene glycol (PEG), 2 g/liter, was added as the nonabsorbable volume marker. A study consisted of a 40-min equilibration period, followed by a 60-min collection period. Samples ofthe perfusate were aspirated at a rate of 1.5 ml/min from the proximal and distal ends of the test segment. Test solutions and aspirated samples were analyzed for PEG, electrolytes, and solutes by previously published methods (5) . Net water and electrolyte movement was calculated by standard nonabsorbable marker equations (6) .
In some studies (see Results), the test solutions contained 0.5 uCi/liter of 24Na and 36C1, which were assayed in a Packard 2425 liquid scintillation spectrometer (Packard Instruments, Downers Grove, Ill.). Unidirectional fluxes were calculated by the equation of Berger and Steele (10) .
In all perfusions, an initial control study, during which saline was infused intravenously, was followed by a VIP period during which VIP was infused intravenously. Previous studies have shown that under control conditions absorption rates are consistent during two consecutive perfusion experiments (11) .
VIP. Pure porcine VIP (Viktor Mutt, Karolinska Institute, Stockholm, Sweden), dissolved in normal saline that contained 0.5% albumin, was infused intravenously at a rate of 200 or 400 pmol/kg per h with a Harvard Apparatus constant infusion pump (Harvard Apparatus Co., Inc., S. Natick, Mass.).
Potential difference. Potential difference (PD) was measured between the perfusion solution, which served as a flowing intraluminal electrode, and a subcutaneous reference electrode (5 Table I ) was perfused in the jejunum, intravenous infusion of VIP at 200 pmol/kg per h resulted in a significant reduction in water and electrolyte absorption when compared with the control period (Table II) . When VIP was infused at 400 pmol/kg per h, the reduction in absorption of water and sodium was even greater, and mean net chloride secretion was observed. Bicarbonate absorption rate was reduced to approximately the same extent by the two doses of VIP; in both instances, bicarbonate absorption was reduced even though mean luminal bicarbonate concentration was higher during the VIP period than during the control period (due to less bicarbonate absorption in the mixing segment). If Table I) , water, sodium, chloride, and bicarbonate were secreted during the control period, when saline was infused intravenously (Table  III) . During intravenous VIP infusion, at either 200 or 400 pmol/kg per h, the jejunal secretion rate of water and electrolytes was enhanced, and the potential difference became more lumen-negative. Although most of these differences were not statistically significant with either dose of VIP, when all the data were combined (regardless of the VIP infusion rate) it was clear that VIP did enhance secretion rate to a small extent during perfusion of the bicarbonate-free solution (P < 0.05 for net water, sodium, chloride, and bicarbonate secretion and PD).
As can be seen by comparing data in Tables II and  III , VIP had much more effect on water and electrolyte movement when the jejunum was perfused with an absorbable balanced electrolyte solution than when it was perfused with a bicarbonate-free solution.
Effect of VIP on unidirectional fluxes of sodium and chloride. During perfusion of the bicarbonatecontaining solution, the chloride lumen-to-plasma flux was reduced with both the 200 and 400 pmol/kg per h dose of VIP when compared with the control period ( Table IV) . The plasma-to-lumen chloride flux was not significantly changed when either 200 or 400 pmol/kg per h VIP was infused, though there was a tendency for it also to decrease with VIP. More or less similar changes occurred in the sodium unidirectional fluxes: there was a significant reduction of sodium lumento-plasma flux with 400 pmol/kg per h VIP, while the plasma-to-lumen sodium flux was not altered to a statistically significant extent.
During perfusion of the bicarbonate-free solution, there was a significant reduction in both lumen-toplasma and plasma-to-lumen chloride fluxes with the 200 and 400 pmol/kg per h VIP infusion (Table IV) . There was no significant change in the sodium fluxes.
Effect of Vasoactive Intestinal Polypeptide on Jejunal Transport effect of VIP on further net bicarbonate absorption. In the earlier study (8) , VIP We have previously provided evidence of active chloride secretion by the normal human jejunum during perfusion of a bicarbonate-free solution (5). Part of the evidence for this was a discrepancy between the observed chloride flux ratio (L --P/P --L) and the chloride flux ratio that would be expected if chloride movement were passive (calculated by Ussing's equation) (12) . As shown in Table V , a similar discrepancy was noted in the present control experiment during perfusion of the bicarbonate-free solution. This discrepancy was also seen during VIP infusion. Although quantitative inferences must be interpreted with caution, it is interesting to note that the difference between the calculated and observed flux ratios (A flux ratio) was significantly greater during the 400 pmol/kg per h VIP infusion than during the control period (P < 0.05). (The A flux ratio was also significantly different when all 11 studies, regardless of VIP dose, were combined [P < 0.01].) These results would be compatible with increased active chloride secretion during VIP infusion.
Effect of VIP on fructose and fructose-stimulated water and electrolyte absorption. Fructose is absorbed from the jejunum by facilitated diffusion by a mechanism that does not (in contrast to glucose) stimulate active sodium absorption (13) . Fructose absorption stimulates the passive absorption of sodium chloride. To evaluate the effect of VIP on absorption of fructose and fructose-stimulated water and electrolyte absorption, the jejunum was perfused in random order with a saline-mannitol solution (solution C, Table I ) and on a separate test day with a salinefructose solution (solution D, Table I ). On each test day the subject received intravenous saline during control period, followed by intravenous VIP at a rate of 200 or 400 pmol/kg per h. The difference in absorption of water and electrolytes between the two solutions when the subject was under the same test condition (i.e., intravenous saline or VIP) represented fructose-stimulated water and electrolyte absorption.
The saline-mannitol solution was infused at a rate of 10 ml/min, whereas the saline-fructose solution was infused at a rate of 13 ml/min. This difference in infusion rates compensated for differences in absorption/secretion rates with fructose and mannitol, so that similar flow rates would be obtained in the test segment (13) , which was 20 cm in this group of studies. (Table VII) .
Effect of VIP on sodium diffusion and on glucosestimulated electrical potential. The jejunum was perfused sequentially with three isotonic test solutions, two containing either mannitol or glucose and a low concentration of sodium chloride (solutions F and G in Table I ) and another that was a balanced electrolyte solution (solution A in Table I During intravenous saline infusion, the PD was lumen-positive (+5.0±0.6 mV) when the jejunum was perfused with a saline-mannitol solution, lumen-negative (-3.8±0.4 mV) when perfused with a balanced electrolyte solution, and even more lumen-negative (-9.0±0.8 mV) when perfused with a saline-glucose solution. The PD was slightly more negative with VIP during perfusion of the balanced electrolyte solution with both the 200 (-4.7±0.9 mV) and 400 (-4.1±0.4 mV) pmol/kg per h dose than during the control period. Neither infusion rate of VIP had any statistically significant effect on the lumen-positive PD during perfusion of solution F (+6.0±1.3 mV, +7.0±1.1 mV, respectively, for the low and high dose of VIP) or on the lumen-negative PD during perfusion of solution G (-10.3±1.4 mV, -10.1±0.9 mV, respectively, for the low and high dose of VIP).
DISCUS SION
Under normal conditions in man, jejunal absorption of a balanced physiological electrolyte solution in vivo is dependent on bicarbonate absorption. Sodium and bicarbonate are absorbed by an active process involving Na/H exchange (4), and water and sodium chloride The present studies show that VIP inhibits jejunal bicarbonate absorption, presumably by inhibition of Na/H exchange. However, it appears unlikely that this is the only mechanism by which VIP inhibits jejunal absorption. This is most evident when one compares the effect of the high and low doses of VIP. Both doses inhibited bicarbonate absorption by -50%, yet the high dose inhibited water and sodium chloride absorption to a much greater extent than the small dose (Table II) . Therefore, the larger dose of VIP must inhibit absorption by some nonbicarbonatemediated mechanism.
The most obvious possibility, in light of previous work in animal experiments in vitro (2) , was that the large dose of VIP might induce more active chloride secretion than the small dose. To evaluate the effect ofVIP on active secretion, we perfused the jejunum with a bicarbonate-free solution, which allows active chloride secretion to be revealed (5) . We found that VIP does stimulate active chloride secretion (this is discussed further in the next to last paragraph of this Discussion); however, the magnitude of this enhanced secretion was rather small, and was not clearly greater with the large than with the small dose of VIP. It thus seemed unlikely that stimulation of active secretion played a major role in the marked inhibition of absorption by the high dose of VIP during jejunal perfusion of the balanced electrolyte solution.
Since inhibition of active bicarbonate absorption and stimulation of active chloride secretion appeared inadequate to explain the observed effect of the large dose of VIP, it seemed possible that VIP might inhibit passive salt and water absorption. To test for this, we evaluated the effect of VIP on fructosestimulated absorption. Fructose was chosen for study because it is rapidly absorbed by the jejunum by a mechanism that does not enhance active electrolyte absorption (13) ; fructose stimulation of water and electrolyte absorption is mediated passively. Fortunately for our purposes, VIP did not inhibit fructose absorption rate, so the extent to which fructose absorption was accompanied by absorption of salt and water could be used to assess the effect of VIP on passive water and salt absorption. The results revealed that the large dose of VIP markedly inhibited fructose-stimulated absorption of sodium chloride and water, whereas the small dose had only a slight inhibitory effect (Table VI) .
The hypothesis that the large dose of VIP inhibits passive movement of sodium chloride and water was tested by an additional experiment. When isotonic solutions containing mannitol are perfused through the jejunum, the jejunum secretes water and sodium chloride. This secretion results from passive forces (6) . If VIP inhibits passive absorption of water and sodium chloride in response to fructose absorption, it should also inhibit passive secretion of water and sodium chloride in response to perfusion with mannitol. The results ofthe experiment supported the hypothesis (Table VII) .
These results offer an explanation for the effect of VIP on jejunal absorption of physiological test solutions. The small dose inhibits absorption mainly because it inhibits bicarbonate absorption, presumably via inhibition of Na/H exchange. This dose of VIP also inhibits passive absorption of water and sodium chloride, and it probably stimulates active chloride secretion, but these effects of the small dose of VIP are relatively unimportant. The This suggests that glucose absorption and glucose stimulation of sodium movement across the brush border and lateral membranes are qualitatively intact during VIP infusion.
During perfusion of either the balanced or the bicarbonate-free solution, the PD was significantly more negative during VIP infusion. This may be due to a stimulation of active chloride secretion (assuming that chloride secretion is electrogenic), since flux ratio analysis suggested enhanced active chloride secretion during VIP infusion. It may seem contradictory to postulate a stimulation of active chloride secretion when plasma-to-lumen flux of chloride tended to fall rather than rise (Table IV) . However, this apparent discrepancy is probably explained by the simultaneous inhibitory effect of VIP on passive chloride movement. In other words, VIP reduces passive chloride diffusion from plasma-to-lumen (and from lumen-to-plasma) and increases active plasma-to-lumen flux; the reduction in passive diffusion is quantitatively greater, so total plasma-to-lumen chloride flux falls in spite of the stimulated active chloride secretion.
From our studies we conclude that the major effect of VIP in the human jejunum in vivo is to decrease normal absorption ofwater and electrolytesnot only active bicarbonate absorption, but also passive absorption of water and sodium chloride in response to osmotic forces generated by active or facilitated solute transport. Although an increase in active chloride secretion does occur, this does not appear to be of major importance, at least not with these doses of VIP. It is possible that larger doses might induce an important, or even dominant, active electrolyte secretion by the jejunum. However, it should be noted that the infusion rates of VIP that we employed result in steady-state plasma VIP concentrations which are well within the range of values found in patients with severe secretory diarrhea apparently caused by VIP-secreting endocrine tumors (8) . So, the doses of VIP which we infused are in the pathophysiological range of interest, even though they do not constitute a full dose-response study. Studies with significantly larger doses of VIP (in terms of a dose-response curve) will probably never be possible in humans because they result in intolerable side effects.
